Ethoxyquin

Unknown Manufacturer

Technical identifiers

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Agents for treatment of diabetic retinopathy and drusen formation in macular degeneration
US 2005137147 A1Applicant: ALCON INCPriority: 2003
EP
US
WO
4 publications
COMPOSITION FOR REGULATION OF MAMMALIAN KERATINOUS TISSUE
EP 1940346 A2Applicant: PROCTER & GAMBLEPriority: 2006
EP
US
2 publications
Pharmaceutical composition for treatment of dementia and cerebrovascular disorders
US 12678431 B2Applicant: YAMADA KEN ICHIPriority: 2019
CN
US
2 publications
Agents for treatment of glaucomatous retinopathy and optic neuropathy
US 2005137146 A1Applicant: ALCON INCPriority: 2004
US
2 publications
Saponin and preservative compositions for reduction of protozoa
US 8048458 B2Applicant: SARTEC CORPPriority: 2008
US
2 publications
Use of coumarin, butylated hydroxyanisole and ethoxyquin for treating grey hair
CN 101095650 BApplicant: OREALPriority: 2006
CN
Catalyst for producing ethyoxyl quinoline
CN 1907564 AApplicant: ZHANG LILIPriority: 2006
CN
Continuous treater for ethoxyquin synthetic liquid
CN 201264977 YApplicant: JIANGSU ZHONGDAN GROUP CO LTDPriority: 2008
CN
Distillation equipment for ethoxyquin production
CN 203989926 UApplicant: TAIXING RUITAI CHEMICAL CO LTDPriority: 2014
CN
Method for producing ethoxyquin
CN 105085392 AApplicant: UNIV XIAMENPriority: 2015
CN